by Fragment based drug discovery includes identifying biologically active small molecule fragments that bind to therapeutic macromolecular drug targets such as enzymes, receptors and other proteins. It is an essential part of structure-based drug design process which aims at developing new chemical entities (NCEs) as drug candidates. Fragment based screening has certain advantages over high throughput screening including identifying fragments that bind to targets with high efficiency and lower molecular weight. This leads to better optimization of hits during lead generation and optimization stages.
The Global Fragment Based Drug Discovery Market is estimated to be valued at US$ 0.795 Bn in 2024 and is expected to exhibit a CAGR of 15% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the Global Fragment Based Drug Discovery are Astex Pharmaceuticals, Beactica AB, Charles River Laboratories International, Inc., Evotec AG, Alveus Pharmaceuticals Pvt. Ltd.
The key opportunities in the fragment based drug discovery market lies in identifying novel fragment hits against difficult protein targets like protein-protein interactions and allosteric sites. There is also a scope for developing new chemical matter starting from fragment hits through lead optimization.
The Global Fragment Based Drug Discovery Market is expected witness high growth in emerging markets of Asia Pacific and Middle East & Africa region owing to increasing investments in pharmaceutical R&D by governments and major players over the forecast period.
Market Drivers
The rising R&D investment in the pharmaceutical industry is one of the major drivers of the Global Fragment Based Drug Discovery Market. According to pharma industry estimates, global R&D spending in pharmaceutical industry is expected to grow at a CAGR of around 6% during 2019-2024. Fragment based screening is becoming an integral part of drug discovery process in light of its advantages over high throughput screening. This is positively impacting the market growth.
PEST Analysis
Political: Government regulations and patent laws could impact the growth of the Global Fragment Based Drug Discovery Market. Changes in healthcare policies may also affect market growth.
Economic: Fragment based drug discovery approach reduces R&D costs and time for developing new drugs. The economic benefits boost investments in this market.
Social: Rising incidence of cancer, infectious diseases, and other complex disorders increases demand for effective new drugs. This drives the adoption of advanced fragment based approaches in the pharmaceutical industry.
Technological: Automation, artificial intelligence, and data analytics are being integrated into fragment based workflows. Use of advanced technologies improves screening efficiency, hit identification, and lead optimization processes.
The Global Fragment Based Drug Discovery Market is primarily concentrated in North America and Europe in terms of value. The United States and major countries of Western Europe such as Germany, the United Kingdom, and France have well-established pharmaceutical industries. Significant research activities are carried out by leading biopharmaceutical and contract research organizations based in these regions. Availability of advanced research infrastructure and skilled professionals further support market growth.
The fragment based drug discovery market is expected to witness the fastest growth in Asia Pacific during the forecast period. This is attributed to rising healthcare expenditures, increasing outsourcing of pharmaceutical R&D to China and India, and growing investments by market players in these countries. Improvements in intellectual property laws are also encouraging global companies to set up research facilities in Asia Pacific. Furthermore, the presence of a large treatment-seeking population makes this a highly lucrative market.
What Are The Key Data Covered In This Global Fragment Based Drug Discovery Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global Fragment Based Drug Discovery Market’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Global Fragment Based Drug Discovery Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Global Fragment Based Drug Discovery Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global Fragment Based Drug Discovery Market vendors
FAQ’s
Q.1 What are the main factors influencing the Global Fragment Based Drug Discovery Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Fragment Based Drug Discovery Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Fragment Based Drug Discovery Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author - Priya Pandey
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement. LinkedIn Profile
